Safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia: Rationale and methods of a phase II randomized trial.

Lang, Jason E; Hornik, Chi D; Martz, Karen; Jacangelo, Juliana; Anand, Ravinder; Greenberg, Rachel; Hornik, Christoph; Zimmerman, Kanecia; Smith, P Brian; Benjamin, Daniel K; Laughon, Matthew

Lang, Jason E; Hornik, Chi D; Martz, Karen; Jacangelo, Juliana; Anand, Ravinder; Greenberg, Rachel; Hornik, Christoph; Zimmerman, Kanecia; Smith, P Brian; Benjamin, Daniel K; Laughon, Matthew.

Afiliación

Lang JE; Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.
Hornik CD; Duke Clinical Research Institute, Durham, NC, USA.
Martz K; Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.
Jacangelo J; Duke Clinical Research Institute, Durham, NC, USA.
Anand R; The Emmes Company, LLC, Rockville, MD, USA.
Greenberg R; The Emmes Company, LLC, Rockville, MD, USA.
Hornik C; The Emmes Company, LLC, Rockville, MD, USA.
Zimmerman K; Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.
Smith PB; Duke Clinical Research Institute, Durham, NC, USA.
Benjamin DK; Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.
Laughon M; Duke Clinical Research Institute, Durham, NC, USA.

Contemp Clin Trials Commun ; 30: 101025, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36345347

Palabras clave

Bronchopulmonary dysplasia; Prematurity; Sildenafil

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 7_ODS3_muertes_prevenibles_nacidos_ninos Problema de salud: 2_muertes_prevenibles / 7_neonatal_care_health Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: Contemp Clin Trials Commun Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google